Global Peptide Therapeutics Drugs Market Size, Status and Forecast 2022

SKU ID : QYR-19701059 | Publishing Date : 14-Dec-2021 | No. of pages : 117

Detailed TOC of Global Peptide Therapeutics Drugs Market Size, Status and Forecast 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Injection
        1.2.3 Oral
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Peptide Therapeutics Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer
        1.3.3 Metabolic Disorders
        1.3.4 Central Nervous System
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Peptide Therapeutics Drugs Market Perspective (2016-2027)
    2.2 Peptide Therapeutics Drugs Growth Trends by Regions
        2.2.1 Peptide Therapeutics Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Peptide Therapeutics Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Peptide Therapeutics Drugs Industry Dynamic
        2.3.1 Peptide Therapeutics Drugs Market Trends
        2.3.2 Peptide Therapeutics Drugs Market Drivers
        2.3.3 Peptide Therapeutics Drugs Market Challenges
        2.3.4 Peptide Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Peptide Therapeutics Drugs Players by Revenue
        3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2016-2021)
        3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue
    3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
        3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2020
    3.5 Peptide Therapeutics Drugs Key Players Head office and Area Served
    3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service
    3.7 Date of Enter into Peptide Therapeutics Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Therapeutics Drugs Breakdown Data by Type
    4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027)

5 Peptide Therapeutics Drugs Breakdown Data by Application
    5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Peptide Therapeutics Drugs Market Size (2016-2027)
    6.2 North America Peptide Therapeutics Drugs Market Size by Type
        6.2.1 North America Peptide Therapeutics Drugs Market Size by Type (2016-2021)
        6.2.2 North America Peptide Therapeutics Drugs Market Size by Type (2022-2027)
        6.2.3 North America Peptide Therapeutics Drugs Market Size by Type (2016-2027)
    6.3 North America Peptide Therapeutics Drugs Market Size by Application
        6.3.1 North America Peptide Therapeutics Drugs Market Size by Application (2016-2021)
        6.3.2 North America Peptide Therapeutics Drugs Market Size by Application (2022-2027)
        6.3.3 North America Peptide Therapeutics Drugs Market Size by Application (2016-2027)
    6.4 North America Peptide Therapeutics Drugs Market Size by Country
        6.4.1 North America Peptide Therapeutics Drugs Market Size by Country (2016-2021)
        6.4.2 North America Peptide Therapeutics Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Peptide Therapeutics Drugs Market Size (2016-2027)
    7.2 Europe Peptide Therapeutics Drugs Market Size by Type
        7.2.1 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2027)
    7.3 Europe Peptide Therapeutics Drugs Market Size by Application
        7.3.1 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2027)
    7.4 Europe Peptide Therapeutics Drugs Market Size by Country
        7.4.1 Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type
        8.2.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application
        8.3.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region
        8.4.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Peptide Therapeutics Drugs Market Size (2016-2027)
    9.2 Latin America Peptide Therapeutics Drugs Market Size by Type
        9.2.1 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2027)
    9.3 Latin America Peptide Therapeutics Drugs Market Size by Application
        9.3.1 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2027)
    9.4 Latin America Peptide Therapeutics Drugs Market Size by Country
        9.4.1 Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type
        10.2.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application
        10.3.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country
        10.4.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
        11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.1.5 Sanofi Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction
        11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.2.5 Eli Lilly Recent Development
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
        11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.3.5 Novo Nordisk Recent Development
    11.4 Takeda
        11.4.1 Takeda Company Details
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Peptide Therapeutics Drugs Introduction
        11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.4.5 Takeda Recent Development
    11.5 Teva
        11.5.1 Teva Company Details
        11.5.2 Teva Business Overview
        11.5.3 Teva Peptide Therapeutics Drugs Introduction
        11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.5.5 Teva Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Peptide Therapeutics Drugs Introduction
        11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.6.5 Novartis Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Details
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction
        11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.7.5 AstraZeneca Recent Development
    11.8 Ipsen
        11.8.1 Ipsen Company Details
        11.8.2 Ipsen Business Overview
        11.8.3 Ipsen Peptide Therapeutics Drugs Introduction
        11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.8.5 Ipsen Recent Development
    11.9 AbbVie
        11.9.1 AbbVie Company Details
        11.9.2 AbbVie Business Overview
        11.9.3 AbbVie Peptide Therapeutics Drugs Introduction
        11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.9.5 AbbVie Recent Development
    11.10 Allergan
        11.10.1 Allergan Company Details
        11.10.2 Allergan Business Overview
        11.10.3 Allergan Peptide Therapeutics Drugs Introduction
        11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.10.5 Allergan Recent Development
    11.11 Ferring
        11.11.1 Ferring Company Details
        11.11.2 Ferring Business Overview
        11.11.3 Ferring Peptide Therapeutics Drugs Introduction
        11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.11.5 Ferring Recent Development
    11.12 Merck
        11.12.1 Merck Company Details
        11.12.2 Merck Business Overview
        11.12.3 Merck Peptide Therapeutics Drugs Introduction
        11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.12.5 Merck Recent Development
    11.13 JNJ
        11.13.1 JNJ Company Details
        11.13.2 JNJ Business Overview
        11.13.3 JNJ Peptide Therapeutics Drugs Introduction
        11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.13.5 JNJ Recent Development
    11.14 Tarix Pharmaceuticals
        11.14.1 Tarix Pharmaceuticals Company Details
        11.14.2 Tarix Pharmaceuticals Business Overview
        11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction
        11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.14.5 Tarix Pharmaceuticals Recent Development
    11.15 Lonza
        11.15.1 Lonza Company Details
        11.15.2 Lonza Business Overview
        11.15.3 Lonza Peptide Therapeutics Drugs Introduction
        11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021)
        11.15.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Peptide Therapeutics Drugs Market Size, Status and Forecast 2022

List of Tables
    Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Injection
    Table 3. Key Players of Oral
    Table 4. Key Players of Other
    Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Peptide Therapeutics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Peptide Therapeutics Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Peptide Therapeutics Drugs Market Share by Regions (2016-2021)
    Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027)
    Table 11. Peptide Therapeutics Drugs Market Trends
    Table 12. Peptide Therapeutics Drugs Market Drivers
    Table 13. Peptide Therapeutics Drugs Market Challenges
    Table 14. Peptide Therapeutics Drugs Market Restraints
    Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2016-2021)
    Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020)
    Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service
    Table 22. Date of Enter into Peptide Therapeutics Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021)
    Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Peptide Therapeutics Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2016-2021)
    Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 62. Sanofi Company Details
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Peptide Therapeutics Drugs Product
    Table 65. Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 66. Sanofi Recent Development
    Table 67. Eli Lilly Company Details
    Table 68. Eli Lilly Business Overview
    Table 69. Eli Lilly Peptide Therapeutics Drugs Product
    Table 70. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 71. Eli Lilly Recent Development
    Table 72. Novo Nordisk Company Details
    Table 73. Novo Nordisk Business Overview
    Table 74. Novo Nordisk Peptide Therapeutics Drugs Product
    Table 75. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 76. Novo Nordisk Recent Development
    Table 77. Takeda Company Details
    Table 78. Takeda Business Overview
    Table 79. Takeda Peptide Therapeutics Drugs Product
    Table 80. Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 81. Takeda Recent Development
    Table 82. Teva Company Details
    Table 83. Teva Business Overview
    Table 84. Teva Peptide Therapeutics Drugs Product
    Table 85. Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 86. Teva Recent Development
    Table 87. Novartis Company Details
    Table 88. Novartis Business Overview
    Table 89. Novartis Peptide Therapeutics Drugs Product
    Table 90. Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 91. Novartis Recent Development
    Table 92. AstraZeneca Company Details
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Peptide Therapeutics Drugs Product
    Table 95. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 96. AstraZeneca Recent Development
    Table 97. Ipsen Company Details
    Table 98. Ipsen Business Overview
    Table 99. Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 100. Ipsen Recent Development
    Table 101. AbbVie Company Details
    Table 102. AbbVie Business Overview
    Table 103. AbbVie Peptide Therapeutics Drugs Product
    Table 104. AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 105. AbbVie Recent Development
    Table 106. Allergan Company Details
    Table 107. Allergan Business Overview
    Table 108. Allergan Peptide Therapeutics Drugs Product
    Table 109. Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 110. Allergan Recent Development
    Table 111. Ferring Company Details
    Table 112. Ferring Business Overview
    Table 113. Ferring Peptide Therapeutics Drugs Product
    Table 114. Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 115. Ferring Recent Development
    Table 116. Merck Company Details
    Table 117. Merck Business Overview
    Table 118. Merck Peptide Therapeutics Drugs Product
    Table 119. Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 120. Merck Recent Development
    Table 121. JNJ Company Details
    Table 122. JNJ Business Overview
    Table 123. JNJ Peptide Therapeutics Drugs Product
    Table 124. JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 125. JNJ Recent Development
    Table 126. Tarix Pharmaceuticals Company Details
    Table 127. Tarix Pharmaceuticals Business Overview
    Table 128. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product
    Table 129. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 130. Tarix Pharmaceuticals Recent Development
    Table 131. Lonza Company Details
    Table 132. Lonza Business Overview
    Table 133. Lonza Peptide Therapeutics Drugs Product
    Table 134. Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
    Table 135. Lonza Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peptide Therapeutics Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Injection Features
    Figure 3. Oral Features
    Figure 4. Other Features
    Figure 5. Global Peptide Therapeutics Drugs Market Share by Application: 2020 VS 2027
    Figure 6. Cancer Case Studies
    Figure 7. Metabolic Disorders Case Studies
    Figure 8. Central Nervous System Case Studies
    Figure 9. Other Case Studies
    Figure 10. Peptide Therapeutics Drugs Report Years Considered
    Figure 11. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Peptide Therapeutics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Peptide Therapeutics Drugs Market Share by Regions: 2020 VS 2027
    Figure 14. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027)
    Figure 15. Global Peptide Therapeutics Drugs Market Share by Players in 2020
    Figure 16. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2020
    Figure 18. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021)
    Figure 19. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027)
    Figure 20. North America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Peptide Therapeutics Drugs Market Share by Type (2016-2027)
    Figure 22. North America Peptide Therapeutics Drugs Market Share by Application (2016-2027)
    Figure 23. North America Peptide Therapeutics Drugs Market Share by Country (2016-2027)
    Figure 24. United States Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Peptide Therapeutics Drugs Market Share by Type (2016-2027)
    Figure 28. Europe Peptide Therapeutics Drugs Market Share by Application (2016-2027)
    Figure 29. Europe Peptide Therapeutics Drugs Market Share by Country (2016-2027)
    Figure 30. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Peptide Therapeutics Drugs Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Peptide Therapeutics Drugs Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2016-2027)
    Figure 40. China Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Peptide Therapeutics Drugs Market Share by Type (2016-2027)
    Figure 48. Latin America Peptide Therapeutics Drugs Market Share by Application (2016-2027)
    Figure 49. Latin America Peptide Therapeutics Drugs Market Share by Country (2016-2027)
    Figure 50. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Peptide Therapeutics Drugs Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Peptide Therapeutics Drugs Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2016-2027)
    Figure 56. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 60. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 61. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 62. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 63. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 65. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 66. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 67. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 68. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 69. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 70. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 71. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 72. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 73. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed

Keyplayers in Global Peptide Therapeutics Drugs Market Size, Status and Forecast 2022

Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
JNJ
Tarix Pharmaceuticals
Lonza

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]